These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9072781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 4. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS, Yang CY, Wong FN, Chen GH, Lien HC, Yeh HZ, Poon SK.
    Hepatogastroenterology; 1999 Dec; 46(28):2713-7. PubMed ID: 10522070
    [Abstract] [Full Text] [Related]

  • 5. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N, Cutler A.
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

  • 8. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W, Dettmer A, Fenner T, Gregor M, Hesse P, Holtmann G, van Husen N, Miederer SE, Schentke KU, Schütz E.
    Z Gastroenterol; 1995 Oct 01; 33(10):598-601. PubMed ID: 7502553
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar 01; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 11. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Triple-therapy treatment during 1 month versus 2 weeks in gastroduodenal disease due to Helicobacter pylori in children].
    Cilleruelo Pascual ML, Urruzuno Tellería P, Román Riechman E, Medina Benítez E, Manzanares López-Manzanares J, Echávarri Olavarría F, Molina Arias M.
    An Esp Pediatr; 1996 May 28; 44(5):456-60. PubMed ID: 8796956
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.